Literature DB >> 23325119

[The "asymptomatic" patient with chronic acquired heart valve disease].

D Horstkotte1, C Prinz, C Piper.   

Abstract

An intervention for chronic acquired valvular heart disease may either be indicated in symptomatic patients to relieve symptoms and improve quality of life or in asymptomatic patients to improve long-term prognosis, e.g., by preventing disease-related complications like chronic heart failure or arrhythmias. For proper action according to current guidelines, the systematic evaluation of symptoms related to the underlying valve disease is of utmost importance. If a discrepancy between symptoms reported or not reported by the patients and the severity of the valve disease is supposed, true absence of symptoms and exercise tolerance should be verified by spiroergometry. In the truly asymptomatic patient with a severe valvular lesion, preservation of myocardial adaption to the chronic volume or pressure overload should be tested utilizing appropriate imaging techniques like radionuclide ventriculography under exercise conditions. The proper evaluation of the functional status is of growing importance in our aging population with its sedentary lifestyle. In this context, the results of a survey should be kept in mind, which indicated that a significant proportion of patients still have interventions too late during the natural history of their valve disease with symptoms of congestive heart failure, arrhythmias, and the risk of sudden cardiac death persisting after a primarily successful valve repair or replacement.

Entities:  

Mesh:

Year:  2013        PMID: 23325119     DOI: 10.1007/s00108-012-3092-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

1.  Balloon valvotomy during pregnancy.

Authors:  Dieter Horstkotte; Dieter Fassbender; Cornelia Piper
Journal:  J Heart Valve Dis       Date:  2005-03

2.  Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay.

Authors:  Patrizio Lancellotti; Erwan Donal; Julien Magne; Marie Moonen; Kim O'Connor; Jean-Claude Daubert; Luc A Pierard
Journal:  Heart       Date:  2010-05-18       Impact factor: 5.994

Review 3.  Aortic stenosis.

Authors:  J Ross; E Braunwald
Journal:  Circulation       Date:  1968-07       Impact factor: 29.690

4.  Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing.

Authors:  M C Amato; P J Moffa; K E Werner; J A Ramires
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

5.  Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function.

Authors:  Hari P Chaliki; Dania Mohty; Jean-Francois Avierinos; Christopher G Scott; Hartzell V Schaff; A Jamil Tajik; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

Review 6.  The natural history of aortic valve stenosis.

Authors:  D Horstkotte; F Loogen
Journal:  Eur Heart J       Date:  1988-04       Impact factor: 29.983

7.  Predictors of outcome in severe, asymptomatic aortic stenosis.

Authors:  R Rosenhek; T Binder; G Porenta; I Lang; G Christ; M Schemper; G Maurer; H Baumgartner
Journal:  N Engl J Med       Date:  2000-08-31       Impact factor: 91.245

8.  Exercise-induced changes in degenerative mitral regurgitation.

Authors:  Julien Magne; Patrizio Lancellotti; Luc A Piérard
Journal:  J Am Coll Cardiol       Date:  2010-07-20       Impact factor: 24.094

Review 9.  Timing of operation in asymptomatic severe aortic stenosis.

Authors:  Hari P Chaliki; Morgan L Brown; Thoralf M Sundt; A Jamil Tajik
Journal:  Expert Rev Cardiovasc Ther       Date:  2007-11

10.  Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database.

Authors:  James M Brown; Sean M O'Brien; Changfu Wu; Jo Ann H Sikora; Bartley P Griffith; James S Gammie
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.